The NXT S-106 Centrifuge is specifically engineered to deliver optimal performance with PRP, PRF, SVF, EXOSOME, and BMAC kits.
Compact yet powerful, it provides unparalleled efficiency and precision for clinical and laboratory use.
NXT S-106 CENTRIFUGE is specially designed to elevate your regenerative medicine applications such as PRP, PRF and SVF to the highest levels. Moreover, it is much more economical with four times longer lifespan compared to standard centrifuges. It maximizes processing success with a 30-50% higher platelet recovery rate compared to fixed rotor centrifuges. Controlled acceleration and deceleration technology ensure maximum stability even for gel-free PRP and PRF products. Perfect compatibility with T-LAB SVF protocol can increase cell concentration up to twice as much as traditional centrifuges. It remains steady without agitation during the stoppage thanks to its perfect balance and does not remix the concentrated valuable cells back into the plasma.
3× Smaller – 60% Lighter – Significantly More Efficient
The NXT S-106 stands out with its space-saving design and lightweight build, ensuring high portability without compromising performance.
Thanks to its controlled acceleration and deceleration technology, the NXT S-106 guarantees maximum stability for all gel-free preparations, including PRP, PRF, SVF, Exosome, and BMAC products.
This precise control minimizes cellular shear stress and optimizes separation consistency.
The swing-out rotor design ensures a significantly higher cell recovery rate, making it ideal for regenerative medicine and stem-cell-based applications where sample integrity is essential.
| Feature | Description |
|---|---|
| Compact & Lightweight | 3× smaller and 60% lighter than traditional centrifuges |
| Advanced Cooling System | Smart ventilation ensures consistent temperature control |
| Precision Rotor Control | Smooth acceleration/deceleration prevents cell damage |
| High Cell Recovery | Swing-out rotor maximizes sample yield |
| Multi-Application Use | Optimized for PRP, PRF, SVF, Exosome, and BMAC protocols |